UPM and Sappi Submit Remedies in EU Review of Proposed JV
UPM and Sappi submitted remedies during the European Commission's review of their proposed joint venture.
Related stories
Adani Ports selected to buy 100% stake in EVOS B.V.
M impact | MNA | Nov 05, 2026, 09:40 AM UTC
Sappi, UPM Offer Remedies to Seek EU Approval for Paper JV
Sappi and UPM have offered remedies in a bid to secure EU antitrust approval for their paper joint venture.
L impact | MNA | Nov 05, 2026, 09:15 AM UTC
AstraZeneca Makes About $10 Billion Offer for Rhythm Pharmaceuticals
AstraZeneca has made an offer of about $10 billion for Rhythm Pharmaceuticals, MT Newswires reports.
M impact | MNA | Nov 05, 2026, 09:07 AM UTC
Air France-KLM Hopes to Complete SAS Deal by Q1 2027
Air France-KLM’s CEO said the company hopes to complete its deal for SAS by Q1 2027.
L impact | MNA | Nov 05, 2026, 09:04 AM UTC
Total Graphite announces acquisition and £0.41m CLN fundraise
M impact | MNA | Nov 05, 2026, 09:00 AM UTC
BL Pharmtech Agrees to Sell 13.96% Stake in Kwangdong Healthbio
BL Pharmtech agreed to sell a 13.96% stake in Kwangdong Healthbio.
M impact | MNA | Nov 05, 2026, 08:58 AM UTC